Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Neuropace Inc. Common Stock
NPCE | US
14.51
USD-0.09
-0.62%
NPCE | US
Loading StockChartView...
About Neuropace Inc. Common Stock
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
07/04/2026
Close
14.51
Open
14.58
High
14.59
Low
14.08
NeuroPace Inc. operates as a medical device company in the United States. It develops and sells RNS system a brain-responsive neuromodulation system that delivers personalized real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator cortical strip leads and depth leads and Patient Remote Monitor as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace Inc. was incorporated in 1997 and is headquartered in Mountain View California.
View LessNPCE | US
Risk
43.0
Sharpe
0.09
Luna's Score
42/100
Recommendation
Sell
Luna says (NPCE | US)
What's Working
Positive Momentum
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
50.1%1 month
43.0%3 months
42.8%6 months
72.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
18.87
Debt to equity
7.45
Debt to assets
0.78
Ent. to EBITDA
-16.94
Ent. to rev.
2.85
PEG
-
Other Fundamentals
EBITDA
-24.60M
MarketCap
423.65M
MarketCap(USD)
423.65M
Div. yield
-
Op. margin
-32.35
Erngs. growth
-
Rev. growth
16.60
Ret. on equity
-192.19
Short ratio
9.24
Short perc.
3.81
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
2.42
Range1M
2.42
Range3M
5.43
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.55
Price X volume
1.72M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -16.94 | 46.09 | Cheaper |
| Ent. to Revenue | 2.85 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 18.87 | 6.21 | Expensive |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 42.75 | 64.12 | Lower Risk |
| Debt to Equity | 7.45 | -145.53 | Expensive |
| Debt to Assets | 0.78 | 0.35 | Expensive |
| Market Cap | 423.65M | 9.70B | Emerging |
